Advertisement

Plasma Ascorbic Acid Concentrations in Prevalent Patients With End-Stage Renal Disease on Hemodialysis

Published:November 06, 2014DOI:https://doi.org/10.1053/j.jrn.2014.09.007

      Objective

      To determine the prevalence of vitamin C (ascorbic acid [AA]) deficiency in patients with end-stage renal disease, the effect of supplemental AA on plasma AA concentrations, and the extrinsic and intrinsic factors that affect plasma AA concentrations in this patient population.

      Design

      In study 1, we compared the effect of hemodialysis (HD) on plasma AA concentrations between patients with low and high pre-HD AA concentrations. In study 2, we analyzed kinetic and nonkinetic factors for their association with increased plasma AA concentrations in patients on maintenance HD. Study 1 was performed in a single outpatient HD clinic in Cherry Hill, New Jersey. Study 2 was performed in 4 outpatient HD clinics in Southern New Jersey.

      Subjects and Intervention

      In study 1, we collected plasma samples from 8 adult patients on maintenance HD at various time points around their HD treatment and assayed them for AA concentration. In study 2, we enrolled 203 adult patients and measured pre-HD plasma AA concentrations. We ascertained supplemental AA use and assessed dietary AA intake.

      Main Outcome Measure

      In study 1, plasma AA concentrations were compared during the intradialytic and interdialytic period. In study 2, pre-HD plasma AA concentrations were correlated with supplement use and demographic factors.

      Results

      Study 1 showed that over the course of a single HD treatment, the plasma AA concentration decreased by a mean (±standard deviation) of 60% (±6.6). In study 2, the median pre-HD plasma AA concentration was 15.7 μM (interquartile range, 8.7-66.8) in patients who did not take a supplement and 50.6 μM (interquartile range, 25.1-88.8) in patients who did take a supplement (P < .001). Supplement use, increasing age, and diabetes mellitus were associated with a pre-HD plasma AA concentration ≥30 μM.

      Conclusion

      HD depletes plasma AA concentrations, and AA supplementation allows patients to achieve higher plasma AA concentrations.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Renal Nutrition
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Horl W.H.
        Anaemia management and mortality risk in chronic kidney disease.
        Nat Rev Nephrol. 2013; 9: 291-301
        • Szczech L.A.
        • Barnhart H.X.
        • Inrig J.K.
        • et al.
        Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.
        Kidney Int. 2008; 74: 791-798
        • Goldberg A.
        The enzymic formation of haem by the incorporation of iron into protoporphyrin; importance of ascorbic acid, ergothioneine and glutathione.
        Br J Haematol. 1959; 5: 150-157
        • Wapnick A.A.
        • Bothwell T.H.
        • Seftel H.
        The relationship between serum ion levels and ascorbic acid stores in siderotic Bantu.
        Br J Haematol. 1970; 19: 271-276
        • Sirover W.D.
        • Siddiqui A.A.
        • Benz R.L.
        Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study.
        Ren Fail. 2008; 30: 884-889
        • Tarng D.C.
        • Wei Y.H.
        • Huang T.P.
        • Kuo B.I.
        • Yang W.C.
        Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
        Kidney Int. 1999; 55: 2477-2486
        • Gastaldello K.
        • Vereerstraeten A.
        • Nzame-Nze T.
        • Vanherweghem J.L.
        • Tielemans C.
        Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration.
        Nephrol Dial Transplant. 1995; 10: 44-47
        • Attallah N.
        • Osman-Malik Y.
        • Frinak S.
        • Besarab A.
        Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
        Am J Kidney Dis. 2006; 47: 644-654
        • Blee T.H.
        • Cogbill T.H.
        • Lambert P.J.
        Hemorrhage associated with vitamin C deficiency in surgical patients.
        Surgery. 2002; 131: 408-412
        • Raynaud-Simon A.
        • Cohen-Bittan J.
        • Gouronnec A.
        • et al.
        Scurvy in hospitalized elderly patients.
        J Nutr Health Aging. 2010; 14: 407-410
        • Baker E.M.
        • Hodges R.E.
        • Hood J.
        • et al.
        Metabolism of 14C- and 3H-labeled L-ascorbic acid in human scurvy.
        Am J Clin Nutr. 1971; 24: 444-454
        • Deicher R.
        • Ziai F.
        • Habicht A.
        • Bieglmayer C.
        • Schillinger M.
        • Horl W.H.
        Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis.
        Nephrol Dial Transplant. 2004; 19: 2319-2324
        • Sullivan J.F.
        • Eisenstein A.B.
        Ascorbic acid depletion in patients undergoing chronic hemodialysis.
        Am J Clin Nutr. 1970; 23: 1339-1346
        • Deicher R.
        • Horl W.H.
        Vitamin C in chronic kidney disease and hemodialysis patients.
        Kidney Blood Press Res. 2003; 26: 100-106
        • Richter A.
        • Kuhlmann M.K.
        • Seibert E.
        • Kotanko P.
        • Levin N.W.
        • Handelman G.J.
        Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients.
        Nephrol Dial Transplant. 2008; 23: 2058-2063
        • Bohm V.
        • Tiroke K.
        • Schneider S.
        • Sperschneider H.
        • Stein G.
        • Bitsch R.
        Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation.
        Int J Vitam Nutr Res. 1997; 67: 262-266
        • Gunnell J.
        • Yeun J.Y.
        • Depner T.A.
        • Kaysen G.A.
        Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.
        Am J Kidney Dis. 1999; 33: 63-72
        • Wang S.
        • Eide T.C.
        • Sogn E.M.
        • Berg K.J.
        • Sund R.B.
        Plasma ascorbic acid in patients undergoing chronic haemodialysis.
        Eur J Clin Pharmacol. 1999; 55: 527-532
        • Kotanko P.
        • Carter M.
        • Levin N.W.
        Intestinal bacterial microflora–a potential source of chronic inflammation in patients with chronic kidney disease.
        Nephrol Dial Transplant. 2006; 21: 2057-2060
        • Levine M.
        • Conry-Cantilena C.
        • Wang Y.
        • et al.
        Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.
        Proc Natl Acad Sci U S A. 1996; 93: 3704-3709
        • Drueke T.B.
        • Parfrey P.S.
        Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s).
        Kidney Int. 2012; 82: 952-960
        • Canavese C.M.
        • Marangella M.
        • Stratta P.
        Think of oxalate when using ascorbate supplementation to optimize iron therapy in dialysis patients.
        Nephrol Dial Transplant. 2008; 23 (author reply 1464): 1463-1464
        • Pru C.
        • Eaton J.
        • Kjellstrand C.
        Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients.
        Nephron. 1985; 39: 112-116
        • Wells C.G.
        • Johnson R.J.
        • Qingli L.
        • Bunt-Milam A.H.
        • Kalina R.E.
        Retinal oxalosis. A clinicopathologic report.
        Arch Ophthalmol. 1989; 107: 1638-1643
        • Salyer W.R.
        • Keren D.
        Oxalosis as a complication of chronic renal failure.
        Kidney Int. 1973; 4: 61-66
        • Daugirdas J.T.
        • Blake P.G.
        • Ing T.S.
        Handbook of Dialysis.
        Lippincott Williams and Wilkins, Philadelphia, PA2006
        • Shi X.F.
        • Ding F.
        • Zhu Q.Y.
        • et al.
        Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
        Ren Fail. 2005; 27: 213-219
        • Costello J.F.
        • Sadovnic M.J.
        • Cottington E.M.
        Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
        J Am Soc Nephrol. 1991; 1: 1289-1298
        • Canavese C.
        • Petrarulo M.
        • Massarenti P.
        • et al.
        Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
        Am J Kidney Dis. 2005; 45: 540-549
        • Price E.A.
        • Mehra R.
        • Holmes T.H.
        • Schrier S.L.
        Anemia in older persons: etiology and evaluation.
        Blood Cells Mol Dis. 2011; 46: 159-165
        • Langlois M.
        • Duprez D.
        • Delanghe J.
        • De Buyzere M.
        • Clement D.L.
        Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis.
        Circulation. 2001; 103: 1863-1868
        • Ferrucci L.
        • Semba R.D.
        • Guralnik J.M.
        Proinflammatory state, hepcidin, and anemia in older persons.
        Blood. 2010; 115: 3810-3816
        • Rizvi S.I.
        • Pandey K.B.
        • Jha R.
        • Maurya P.K.
        Ascorbate recycling by erythrocytes during aging in humans.
        Rejuvenation Res. 2009; 12: 3-6
        • Handelman G.J.
        • Walter M.F.
        • Adhikarla R.
        Elevated plasma F2-isoprostanes in patients on long-term hemodialysis.
        Kidney Int. 2001; 59: 1960-1966
        • Kimmel P.L.
        • Chawla L.S.
        • Amarasinghe A.
        • et al.
        Anthropometric measures, cytokines and survival in haemodialysis patients.
        Nephrol Dial Transplant. 2003; 18: 326-332
        • Kalantar-Zadeh K.
        • Brennan M.L.
        • Hazen S.L.
        Serum myeloperoxidase and mortality in maintenance hemodialysis patients.
        Am J Kidney Dis. 2006; 48: 59-68
        • Wann J.G.
        • Lin C.S.
        • Chang L.C.
        • et al.
        Enhanced expression of glucose transporter 1 on erythrocyte membrane in hemodialysis patients: the possible role in erythrocyte ascorbate recycling.
        Am J Kidney Dis. 2006; 47: 1055-1063
        • Wertheimer E.
        • Sasson S.
        • Cerasi E.
        • Ben-Neriah Y.
        The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein family of stress-inducible proteins.
        Proc Natl Acad Sci U S A. 1991; 88: 2525-2529
        • Lindenmeyer M.T.
        • Rastaldi M.P.
        • Ikehata M.
        • et al.
        Proteinuria and hyperglycemia induce endoplasmic reticulum stress.
        J Am Soc Nephrol. 2008; 19: 2225-2236
        • Bishu K.
        • Agarwal R.
        Acute injury with intravenous iron and concerns regarding long-term safety.
        Clin J Am Soc Nephrol. 2006; 1: S19-S23
        • Fumeron C.
        • Nguyen-Khoa T.
        • Saltiel C.
        • et al.
        Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients.
        Nephrol Dial Transplant. 2005; 20: 1874-1879
        • Conner T.A.
        • McQuade C.
        • Olp J.
        • Pai A.B.
        Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.
        Biometals. 2012; 25: 961-969
        • Matteucci E.
        • Cupisti A.
        • Caprioli R.
        • et al.
        Erythrocyte transmembrane electron transfer in haemodialysis patients.
        Nutr Metab Cardiovasc Dis. 2007; 17: 288-293
        • Kalantar-Zadeh K.
        • Regidor D.L.
        • Kovesdy C.P.
        • et al.
        Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.
        Circulation. 2009; 119: 671-679